Nephrotic syndrome associated with anti-tumor necrosis factor α therapy in a patient with rheumatoid arthritis:: comment on the article by Charles et al -: Reply

被引:0
|
作者
Maini, RN [1 ]
Charles, P [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, London, England
来源
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 06期
关键词
D O I
10.1002/art.10350
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1693 / 1693
页数:1
相关论文
共 50 条
  • [31] Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor α blockade:: comment on the article by Buch et al -: Reply
    Buch, MH
    Bingham, SJ
    Seto, Y
    McGonagle, D
    Bejarano, V
    White, J
    Emery, P
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : 3050 - 3051
  • [32] Graves' Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy
    Shin, Jae Il
    Kim, Min Jung
    Lee, Jae Seung
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) : 449 - 450
  • [33] Tumor necrosis factor α blockers and metastases:: comment on the article by Setoguchi et al -: Reply
    Setoguchi, Soko
    Solomon, Daniel H.
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Glynn, Robert J.
    Cook, E. Francis
    Carney, Greg
    Schneeweiss, Sebastian
    ARTHRITIS AND RHEUMATISM, 2007, 56 (02): : 696 - 696
  • [34] Anti-Tumor Necrosis Factor-alpha Therapy Provokes Latent Leishmaniasis in a Patient with Rheumatoid Arthritis
    Franklin, Gillian
    Greenspan, Joel
    Chen, Sheng
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2009, 39 (02): : 192 - 195
  • [35] Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis
    Haerter, G
    Manfras, BJ
    de Jong-Hesse, Y
    Wilts, H
    Mertens, T
    Kern, P
    Schmitt, M
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) : E88 - E94
  • [36] Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: comment on the article by Taylor et al
    Smith, MD
    Ahern, MJ
    Roberts-Thomson, PJ
    Youssef, PP
    ARTHRITIS AND RHEUMATISM, 2001, 44 (01): : 245 - 245
  • [37] Anti-tumor necrosis factor therapy was not associated with greater risk for mortality than standard therapy in rheumatoid arthritis
    Schattner, Ami
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (06) : JC3 - 13
  • [38] Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy
    Curtis, Jeffrey R.
    John, Ani
    Baser, Onur
    ARTHRITIS CARE & RESEARCH, 2012, 64 (09) : 1282 - 1291
  • [39] Use of Anti-Tumor Necrosis Factor Therapy Is Associated with Reduced Cardiovascular Event Risk in Rheumatoid Arthritis
    Nurmohamed, Mike
    Bao, Yanjun
    Signorovitch, James
    Mulani, Parvez M.
    Furst, Daniel E.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S531 - S531
  • [40] Rheumatoid Arthritis Risk Allele PTPRC Is Also Associated With Response to Anti-Tumor Necrosis Factor α Therapy
    Cui, Jing
    Saevarsdottir, Saedis
    Thomson, Brian
    Padyukov, Leonid
    van der Helm-van Mil, Annette H. M.
    Nititham, Joanne
    Hughes, Laura B.
    de Vries, Niek
    Raychaudhuri, Soumya
    Alfredsson, Lars
    Askling, Johan
    Wedren, Sara
    Ding, Bo
    Guiducci, Candace
    Wolbink, Gert Jan
    Crusius, J. Bart A.
    van der Horst-Bruinsma, Irene E.
    Herenius, Marieke
    Weinblatt, Michael E.
    Shadick, Nancy A.
    Worthington, Jane
    Batliwalla, Franak
    Kern, Marlena
    Morgan, Ann W.
    Wilson, Anthony G.
    Isaacs, John D.
    Hyrich, Kimme
    Seldin, Michael F.
    Moreland, Larry W.
    Behrens, Timothy W.
    Allaart, Cornelia F.
    Criswell, Lindsey A.
    Huizinga, Tom W. J.
    Tak, Paul P.
    Bridges, S. Louis, Jr.
    Toes, Rene E. M.
    Barton, Anne
    Klareskog, Lars
    Gregersen, Peter K.
    Karlson, Elizabeth W.
    Plenge, Robert M.
    ARTHRITIS AND RHEUMATISM, 2010, 62 (07): : 1849 - 1861